SCPH - scPharmaceuticals Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

scPharmaceuticals Inc.

2400 District Avenue
Suite 310
Burlington, MA 01803
United States

Full Time Employees21

Key Executives

NameTitlePayExercisedYear Born
Mr. John H. TuckerPres, CEO, CFO & Director604.05kN/A1963
Dr. Klaus R. Veitinger M.B.A., M.D., MBA, Ph.D.Independent Director37.5kN/A1962
Ms. Rachael NokesSr. VP of Fin. & Principal Accounting OfficerN/AN/A1975
Katherine TaudvinDirector of Corp. Devel. & Investor RelationsN/AN/AN/A
Dr. John Mohr Pharm.D.Sr. VP of Clinical Devel. & Medical AffairsN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is Furoscix that consists of proprietary subcutaneous formulation of furosemide, which is delivered through the SmartDose drug delivery system for treatment of congestion in decompensated heart failure patients outside of the acute care setting. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. to incorporate SmartDose drug delivery system with Furoscix. The company was founded in 2013 and is headquartered in Burlington, Massachusetts.

Corporate Governance

scPharmaceuticals Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.